Raloxifene hydrochloride

Raloxifene Hydrochloride is the hydrochloride salt form of raloxifene, a selective benzothiophene estrogen receptor modulator (SERM) with lipid lowering effects and activity against osteoporosis. Raloxifene hydrochloride specifically binds to estrogen receptors in responsive tissue, including liver, bone, breast, and endometrium. Its therapeutic use is listed as anti-osteoporosis agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Raloxifene HCl, Keoxifene hydrochloride, Optruma and Ostiral. Its PubChem CID is 54900.

CAS No 82640-04-8
Molecular Formula C28H28ClNO4S
Molecular Weight 510.0 g/mol
Synonyms [6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone;hydrochloride

Frequently Asked Questions